These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17578924)

  • 1. Amyloidogenic potential of foie gras.
    Solomon A; Richey T; Murphy CL; Weiss DT; Wall JS; Westermark GT; Westermark P
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10998-1001. PubMed ID: 17578924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmissibility of systemic amyloidosis by a prion-like mechanism.
    Lundmark K; Westermark GT; Nyström S; Murphy CL; Solomon A; Westermark P
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6979-84. PubMed ID: 12011456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis.
    Elliott-Bryant R; Cathcart ES
    Clin Immunol Immunopathol; 1998 Jul; 88(1):65-9. PubMed ID: 9683551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism.
    Tasaki M; Ueda M; Ochiai S; Tanabe Y; Murata S; Misumi Y; Su Y; Sun X; Shinriki S; Jono H; Shono M; Obayashi K; Ando Y
    Biochem Biophys Res Commun; 2010 Oct; 400(4):559-62. PubMed ID: 20807507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.
    Omoto M; Yokota T; Cui D; Hoshii Y; Kawano H; Gondo T; Ishihara T; Kanda T
    Med Mol Morphol; 2007 Jun; 40(2):88-94. PubMed ID: 17572844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-enhancing factor: production and response in amyloidosis-susceptible and -resistant mouse strains.
    Gervais F; Hébert L; Skamene E
    J Leukoc Biol; 1988 Apr; 43(4):311-6. PubMed ID: 3162509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of mule duck in goose foie gras using TaqMan real-time Polymerase Chain Reaction.
    Rodríguez MA; García T; González I; Asensio L; Hernández PE; Martín R
    J Agric Food Chem; 2004 Mar; 52(6):1478-83. PubMed ID: 15030199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of amyloid enhancing factor: clinical and experimental implications.
    Shtrasburg S; Pras M; Brezniak N; Livneh A
    Clin Exp Rheumatol; 1998; 16(3):299-302. PubMed ID: 9631753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet, amyloid enhancing factor (AEF) and amyloidogenesis: an hypothesis.
    Cathcart ES; Elliott-Bryant R
    Amyloid; 1999 Jun; 6(2):107-13. PubMed ID: 10439116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review. Reflections on amyloidosis in Papua New Guinea.
    Westermark P; Westermark GT
    Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3701-5. PubMed ID: 18849285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis and biochemistry of amyloidosis.
    Cohen AS; Connors LH
    J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA; Kandel R; Cathcart ES
    Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusible amyloid oligomers trigger systemic amyloidosis in mice.
    Senthilkumar S; Chang E; Jayakumar R
    Biochem J; 2008 Oct; 415(2):207-15. PubMed ID: 18564059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic macrophage activation and functions in amyloid enhancing factor-induced secondary amyloidosis. Study of phagocytosis, killing, respiratory burst, and MHC class II surface expression.
    Reid C; Hébert L; Pozzulo G; Gervais F
    J Leukoc Biol; 1993 Jun; 53(6):651-7. PubMed ID: 8391054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.